Hutch News
Results per Page:
Dr. Stanley Riddell awarded Burke O'Reilly Family Endowed Chair in Immunotherapy
Inspired by child's life-threatening illness, family's gift funds development of next-gen therapies
New protocols, precision approaches ahead for lung cancer
Hutch researchers launch liquid biopsy study; large biomarker protocol publishes, providing ‘roadmap’ for treatment of metastatic patients
New Scientific Publications
Each week, Fred Hutch librarians search PubMed and Web of Science to discover new papers published by Fred Hutch authors
Week of November 22, 2020
Sifting through the haystack: Optimizing hematopoietic stem cell purification for gene therapy
From the Kiem Lab, Clinical Research Division
If at first you don’t succeed: Testing outcomes of second CAR T-cell infusions
From the Turtle group and collaborators, Clinical Research Division
Targeted immunotherapy for deadly prostate cancer shows promise in preclinical test
Antibody-drug conjugate could be step toward selective treatment for neuroendocrine prostate cancer
Breast cancer researchers from Hutch / UW Cancer Consortium gain BCRF funding
New grants will support studies aimed at bettering patient outcomes through diet, exercise, vaccines and more
Cancer clinical trials: Creativity in the face of COVID-19
Faced with a global pandemic, scientists prioritize safety, patient benefit
T cells recognize novel cancer-specific antigen derived from leukemic gene fusion
From the Bleakley lab, Clinical Research Division
Rewiring T cell death signaling enhances T cell function and persistence
From the Greenberg lab, Clinical Research Division
Timothy Ray Brown, who inspired millions living with HIV, dies of leukemia
For more than a decade after a stem cell transplant, he was the only person known to be cured of HIV/AIDS
New Brave Fellowship powers Dr. Alyssa Webster’s race for new leukemia cures
Running community funded new program to develop leaders in rare cancer research and advocates for diversity in science
Fred Hutch Evergreen Fund awards six grants to promising projects
Scientists receive up to $200K to boost research for projects deemed to have partnership potential
Antigen boost helps CAR-T cells control viral load in SHIV infected animals
From the Kiem Group, Clinical Research Division
Immunotherapy trial in advanced bladder and other urinary tract cancers shows 'exciting' results
'Practice-changing' data shows patients with advanced urothelial carcinoma survive longer with immune-boosting drug after chemo
Tip Sheet: Colorectal cancer, COVID-19 super-spreading, gene therapy for herpes, contagious cancer in Tasmanian devils – and more
Summaries of recent Fred Hutch research findings and other news with links for additional background and media contacts.
Experimental, precision strategy targets unique cancer protein found in certain acute myeloid leukemia cases
Lab study shows promise of aiming genetically engineered T-cell therapy at a gene fusion
Can a tumor that acts like a microbe help us develop better cancer therapies?
Understanding the genetics underlying spontaneous regression of an infectious tumor in Tasmanian devils could point us toward new treatment targets
WATCH: Why Dr. Andrew Hsieh is optimistic about the future of treatment for bladder cancer
Physician-scientist aims to make a difference for patients with 'understudied' cancer
$3.4 million grant to find safer, more effective leukemia treatments
New combinatorial targeted therapies before haploidentical bone marrow transplantation for AML could also help expand access to potential cures for underserved populations
Notch signaling promotes chemoresistance in FLT3-amplified acute myeloid leukemia
From the Bernstein Group, Clinical Research Division